Triglyceride-rich remnant lipoproteins are more atherogenic than LDL per particle: is this important?
Anne Tybjærg‐Hansen, Børge G. Nordestgaard, Mette Christoffersen
Abstract
RCTs of triglyceride lowering drugs: Inconsistent results on MACE risk reductionTriglyceride-rich remnant lipoproteins are more atherogenic than LDL per particle
Topics & Concepts
MedicineTriglycerideInternal medicineLdl cholesterolTriglycerides bloodEndocrinologyCholesterolCholesterol and Lipid MetabolismDiabetes, Cardiovascular Risks, and LipoproteinsCancer, Lipids, and Metabolism